SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:gup.ub.gu.se/290192"
 

Search: id:"swepub:oai:gup.ub.gu.se/290192" > Antiretroviral trea...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Antiretroviral treatment for HIV infection: Swedish recommendations 2019

Eriksen, J. (author)
Karolinska Institutet
Carlander, C. (author)
Karolinska Institutet
Albert, J. (author)
Karolinska Institutet
show more...
Flamholc, L. (author)
Gisslén, Magnus, 1962 (author)
Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för infektionssjukdomar,Institute of Biomedicine, Department of Infectious Medicine
Naver, L. (author)
Karolinska Institutet
Svedhem, V. (author)
Karolinska Institutet
Yilmaz, Aylin, 1974 (author)
Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för infektionssjukdomar,Institute of Biomedicine, Department of Infectious Medicine
Sonnerborg, A. (author)
Karolinska Institutet
show less...
 (creator_code:org_t)
2020-01-11
2020
English.
In: Infectious Diseases. - : Informa UK Limited. - 2374-4235 .- 2374-4243. ; 52:5, s. 295-329
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The Swedish Reference Group for Antiviral Therapy (RAV) published recommendations for the treatment of HIV infection in this journal most recently in 2017. An expert group under the guidance of RAV here provides updated recommendations. The most important updates in the present guidelines are the following: (a) The risk of HIV transmission through condomless sex from individuals with fully suppressed HIV viral load is effectively zero. (b) Pre-exposure prophylaxis (PrEP) is recommended for groups with a high risk of HIV infection. (c) Since the last update, two new substances have been registered: bictegravir and doravirine. (d) Dual treatment may be an alternative in selected patients, using lamivudine + dolutegravir or lamivudine + boosted darunavir/atazanavir. As with previous publications, recommendations are evidence-graded in accordance with the Oxford Centre for Evidence Based Medicine. This document does not cover treatment of opportunistic infections and tumours.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Infectious Medicine (hsv//eng)

Keyword

Antiretroviral
HIV
treatment guidelines
Sweden
adult
paediatric
tenofovir disoproxil fumarate
cervical intraepithelial neoplasia
human-papillomavirus vaccine
randomized double-blind
once-daily
dolutegravir
public-health agency
short-term risk
initial treatment
hiv-1-infected patients
drug-resistance
Infectious Diseases

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view